The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.

@article{Robinson2008TheST,
  title={The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.},
  author={D. S. Robinson and Jay D. Amsterdam},
  journal={Journal of affective disorders},
  year={2008},
  volume={105 1-3},
  pages={15-23}
}
BACKGROUND Monoamine oxidase inhibitors (MAOIs) are highly efficacious antidepressants, but safety concerns have limited their broad use. METHODS We reviewed key safety and tolerability data from all clinical trials of patients with major depressive disorder (MDD) accrued during the clinical development of the selegiline transdermal system (STS), as reported to the Food and Drug Administration. This review includes data from both controlled and uncontrolled clinical trials involving STS… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…